Share:
New York, April 16, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Breast Ultrasound Market Research Report by Product, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p06063118/?utm source=GNW
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Breast Ultrasound Market is expected to grow from USD 2,149.67 Million in 2020 to USD 3,403.67 Million by the end of 2025.
2. The Global Breast Ultrasound Market is expected to grow from EUR 1,884.87 Million in 2020 to EUR 2,984.40 Million by the end of 2025.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
SmartBreast™ Acquires Molecular Breast Imaging Assets from GE Healthcare
February 8, 2021 GMT
PITTSBURGH, Feb. 8, 2021 /PRNewswire/ SmartBreast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and diagnosis, announced today that it has acquired the Discovery NM750b Molecular Breast Imaging (MBI) assets from GE Healthcare, including the MBI scanner designs, manufacturing tools, instructions, related patents and the installed-base service business.
The Discovery NM750b is installed at scores of sites worldwide. SmartBreast will manufacture, market and distribute the MBI scanner, rebranded as “EVE CLEAR SCAN e750.”
SmartBreast™ Acquires Molecular Breast Imaging Assets from Dilon Technologies®
News provided by
Share this article
PITTSBURGH, Dec. 29, 2020 /PRNewswire/
Smart Breast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount.
Dilon D6800 MBI scanner acquired by SmartBreast.
Comparison of mammogram in dense breast tissue that appeared “normal” and the MBI scan which detects a hidden early stage invasive cancer (courtesy of Mayo Clinic).
The acquired MBI technology sees through dense breast tissue to find 3 to 4 times more cancers than mammography alone.